Janssen Biotech, Inc.
Clinical trials sponsored by Janssen Biotech, Inc., explained in plain language.
-
Simponi under the microscope: new registry tracks Long-Term risks in ulcerative colitis patients
Knowledge-focused OngoingThis registry follows 535 adults with moderate-to-severe ulcerative colitis who are taking or starting Simponi. Researchers will track serious side effects like infections, cancers, and pregnancy outcomes over time. The goal is to better understand the long-term safety of this me…
Sponsor: Janssen Biotech, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Massive study tracks IBD drug safety in kids for years
Knowledge-focused OngoingThis study follows nearly 5,000 children with Crohn's disease, ulcerative colitis, or indeterminate colitis to monitor the long-term safety of their treatments, including the drug infliximab. Researchers collect information on side effects, disease activity, and quality of life o…
Sponsor: Janssen Biotech, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC